The European Commission has approved the first plant-derived cannabis-based medicine for the treatment of seizures in patients suffering from two rare, severe forms of childhood-onset epilepsy. / read more /
ABPI has issued a response to the recently published report from the National Audit Office (NAO) on the impact Brexit may have on medicines supply. / read more /
advertisement
Subscribe
Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.
AstraZeneca and GlaxoSmithKline have been ranked in the top 20 companies for outstanding efforts in sustainability performance in the FTSE 100 Index climate change business leaderboard, published by EcoAct. / read more /
The project focused on accelerating the discovery and development of monoclonal antibodies and aimed to tackle the limitations in the biologics supply chain. / read more /
The Committee for Medicinal Products for Human Use of the European Medicines Agency has granted a positive opinion recommending marketing authorization for Bavencio (avelumab) in combination with axitinib for treating kidney cancer. / read more /
The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended the approval of AstraZeneca's Qtrilmet (metformin hydrochloride, saxagliptin, and dapagliflozin) modified-release tablets for treating type-2 diabetes. / read more /
The companies have advanced their collaboration to the next stage and will continue to develop a plant-based biosimilar candidate to Roche's Rituxan. / read more /
Under a new co-development license agreement, Boehringer Ingelheim and Inflammasome Therapeutics aim to develop novel therapies for retinal diseases. / read more /
The new microscope gives fast, deep, and clear images for live observation over long periods and allows scientists to study a larger range of applications. / read more /
The editors explore novel technologies for the formulation, manufacture,
purification, and delivery of sterile small- and large-molecule drugs including single-use systems, facilities and equipment, contamination issues, and process analytics.
